Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biologic Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01960855
What this trial is testing

A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy

Who this might be right for
Rheumatoid Arthritis
AbbVie 276
Large-scale testing (Phase 3)UnknownNCT03083743
What this trial is testing

A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection

Who this might be right for
Non-small-cell Lung Cancer (NSCLC) Stage IV
Shanghai Gebaide Biotechnology Co., Ltd. 417
Not applicableNot Yet RecruitingNCT07803159
What this trial is testing

Frailty, Immunonutrition, Surgery Type, and Biologic Recovery in Elderly Gastric Cancer

Who this might be right for
Gastric CancerGastric Adenocarcinoma
Kocaeli City Hospital 328
Testing effectiveness (Phase 2)Ended earlyNCT00243308
What this trial is testing

Serp-1 for the Treatment of Acute Coronary Syndrome

Who this might be right for
Unstable AnginaCoronary AtherosclerosisCoronary Restenosis
Viron Therapeutics Inc 72
Testing effectiveness (Phase 2)Ended earlyNCT01636817
What this trial is testing

A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics

Who this might be right for
InflammationRheumatoid Arthritis
Novo Nordisk A/S 239
Early research (Phase 1)Study completedNCT00366418
What this trial is testing

Lower But More Frequent Dose Rituximab to Treat Chronic Lymphocytic Leukemia

Who this might be right for
Refractory Chronic Lymphocytic Leukemia
National Heart, Lung, and Blood Institute (NHLBI) 4
Early research (Phase 1)Study completedNCT01621490
What this trial is testing

PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma

Who this might be right for
Advanced MelanomaMetastatic Melanoma
Bristol-Myers Squibb 170
Testing effectiveness (Phase 2)Looking for participantsNCT06059690
What this trial is testing

Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells

Who this might be right for
Glioblastoma MultiformeGlycolytic IndexEpidermal Growth Factor Receptor
Jonsson Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT01970306
What this trial is testing

Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material

Who this might be right for
Esophageal Adenocarcinoma
Memorial Sloan Kettering Cancer Center 78
Not applicableLooking for participantsNCT05694325
What this trial is testing

Biologic Characterization of Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Gruppo Italiano Malattie EMatologiche dell'Adulto 200
Not applicableUnknownNCT04681326
What this trial is testing

Prophylactic Implantation of Biologic Mesh in Peritonitis

Who this might be right for
Incisional HerniaPeritonitis
Azienda Ospedaliero-Universitaria di Parma 90
Not applicableStudy completedNCT05447182
What this trial is testing

People-Powered Medicine (PPM): Rheumatoid Arthritis Non-responders to Biologic Therapies (RANT)

Who this might be right for
Rheumatoid Arthritis
Brigham and Women's Hospital 300
Testing effectiveness (Phase 2)Study completedNCT00015990
What this trial is testing

Thalidomide in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
Chronic Myelomonocytic Leukemiade Novo Myelodysplastic SyndromesPreviously Treated Myelodysplastic Syndromes+5 more
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Looking for participantsNCT04134559
What this trial is testing

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma, ChildhoodFibrolamellar CarcinomaLiver Cancer+1 more
Allison O'Neill, MD 18
Not applicableStudy completedNCT00099697
What this trial is testing

Biologic Effects of Dehydroepiandrosterone (DHEA) in Humans

Who this might be right for
AgingObesityInsulin Resistance
National Institute on Aging (NIA) 56
Early research (Phase 1)WithdrawnNCT01843491
What this trial is testing

A Phase I Clinical Trial Immunizing Healthy Adults With the NMRC-M3V-Ad-PfCA Vaccine to Generate Biologic Reagents

Who this might be right for
HealthyMalaria
U.S. Army Medical Research and Development Command
Not applicableLooking for participantsNCT07470502
What this trial is testing

MICI-BIO: Study on Patient With Chronic Inflammatory Bowel Disease

Who this might be right for
IBD (Inflammatory Bowel Disease)
Meyer Children's Hospital IRCCS 15
Not applicableEnrolling By InvitationNCT07161128
What this trial is testing

Gait Pattern Analysis After Arthroscopic Treament of Osteochondral Defects of Talus

Who this might be right for
Osteochondral Defects of TalusGait AnalysisMicrofracture Procedure+1 more
Gazi University 60
Not applicableStudy completedNCT00581412
What this trial is testing

Composite Graft Use in Abdominal Sacrocolpopexy Reduces Erosion Rates

Who this might be right for
Pelvic Organ Prolapse
University of California, Irvine 60
Not applicableLooking for participantsNCT07522528
What this trial is testing

Biologics and Paediatric Enteral Nutrition in Crohn's Disease Study

Who this might be right for
Crohn's Disease (CD)
University of Glasgow 90
Next Page